Acute electrophysiologic effects of inhaled salbutamol in humans

Chest

Volumn 127, Issue 6, 2005, Pages 2057-2063

  Kallergis, Eleftherios M ^a   Manios, Emmanuel G ^a   Kanoupakis, Emmanuel M ^a   Schiza, Sophia E ^a   Mavrakis, Hercules E ^a   Klapsinos, Nikolaos K ^a   Vardas, Panos E ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Electrophysiologic effects; Refractory period; Salbutamol; 2 agonist

Indexed keywords

SALBUTAMOL; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ADULT; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; ELECTROGRAPHY; ELECTROPHYSIOLOGY; FEMALE; HEART DEPOLARIZATION; HEART RATE; HIS BUNDLE; HUMAN; MALE; NEBULIZER; PRIORITY JOURNAL; REFRACTORY PERIOD; SINGLE DRUG DOSE; SINUS NODE RECOVERY TIME; WENCKEBACH PERIOD; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; ELECTROCARDIOGRAPHY; HEART ATRIOVENTRICULAR NODE; HEART FUNCTION TEST; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CONDUCTION SYSTEM; HEART RIGHT VENTRICLE FUNCTION; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; ALBUTEROL; ASTHMA; ATRIOVENTRICULAR NODE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT;

EID: 21844479048     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.127.6.2057     Document Type: Article

References (33)

1. Zipes DP. Sympathetic stimulation and arrhythmias. N Engl J Med 1991; 325:656-657
2. Kaumann AJ, Sanders L. Both β1- and β2-adrenoceptors mediate catecholamine-evoked arrhythmias in isolated human right atrium. Naunyn Schmiedebergs Arch Pharmacol 1993; 348:536-540
3. Han J, de Jalon G, Moe GK. Adrenergic effects on ventricular vulnerability. Circ Res 1964; 14:516-524
4. 2- adrenergic stimulation in animals susceptible to sudden death. Circulation 1997; 96:1914-1922
5. 1-adrenergic receptor mRNA in heart failure. J Am Coll Cardiol 1996; 27:146-154
6. Bristow MR. Changes in myocardial and vascular receptors in heart failure. J Am Coll Cardiol 1993; 22(Suppl):61A-71A
7. Bristow MR, Hershberger RE, Port JD, et al. β-Adrenergic pathways in nonfailing and failing human ventricular myocardium. Circulation 1990; 82(suppl 2):I12-I25
8. 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 1991; 43:203-242
9. Crane J, Burgess C, Beasley R. Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline. Thorax 1989; 44:136-140
10. Flatt A, Crane J, Purdie G, et al. The cardiovascular effects of β adrenergic agonist drugs administered by nebulization. Postgrad Med J 1990; 66:98-101
11. Wong CS, Pavord ID, Williams J, et al. Bronchodilator, cardiovascular and hypokalaemic effects of fenoterol, salbutamol and terbutaline in asthma. Lancet 1990; 336:1396-1399
12. Al-Hillawi AH, Hayward R, Johnson NM. Incidence of cardiac arrhythmias in patients taking slow release salbutamol and slow release terbutaline for asthma. BMJ 1984; 288:367
13. Salpeter SR, Ormiston TM, Salpeter EE. Cardiovascular effects of β-agonists in patients with asthma and COPD: a meta-analysis. Chest 2004; 125:2309-2321
14. Lemaitre RN, Siscovick DS, Psaty BM, et al. Inhaled β-2 adrenergic receptor agonists and primary cardiac arrest. Am J Med 2002; 113:711-716
15. Suissa S, Hemmelgarn B, Blais L, et al. Bronchodilators and acute cardiac death. Am J Respir Crit Care Med 1996; 154:1598-1602
16. Celli BR, MacNee W. ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23:932-946
17. Josephson ME. Electrophysiologic investigation: general concepts. In: Josephson ME, ed. Clinical cardiac electrophysiology: techniques and interpretations. 2nded. Philadelphia, PA: Lippincott, Williams, and Wilkins, 1993; 22-70
18. Josephson ME. Sinus node function. In: Josephson ME, ed. Clinical cardiac electrophysiology: techniques and interpretations. 2nd ed. Philadelphia, PA: Lippincott, Williams, and Wilkins, 1993; 71-95
19. Janson C. Plasma levels and effects of salbutamol after inhaled or i.v. administration in stable asthma. Eur Respir J 1991; 4:544-550
20. Wit AL, Hoffman BF, Rosen MR. Electrophysiology and pharmacology of arrhythmias: IX. Cardiac electrophysiologic effects of β-adrenergic receptor stimulation and blockade. Part A. Am Heart J 1975; 90:521-533
21. Stiles GL, Taylor S, Lefkowitz RJ. Human cardiac β-adrenergic receptors: subtype heterogeneity delineated by direct radioligand binding. Life Sci 1983; 33:467-473
22. Buxton BF, Jones CR, Molenaar P, et al. Characterization and autoradiographic localization of β-adrenoceptors in human cardiac tissues. Br J Pharmacol 1987; 92:299-310
23. Brodde OE, Michel MC. Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev 1999; 51:651-690
24. 2-Adrenergic receptors mediate important electrophysiological effects in human ventricular myocardium. Heart 2001; 86:45-51
25. 2-adrenoceptors in the human heart. Circ Res 1989; 65:546-553
26. 2-adrenoceptors in the transplanted human heart. J Cardiovasc Pharmacol 1997; 30:811-816
27. Komadina KH, Carlson TA, Strollo PJ, et al. Electrophysiologic study of the effects of aminophylline and metaproterenol on canine myocardium. Chest 1992; 101:232-238
28. 2-selective agonist. J Cardiovasc Electrophysiol 2004; 15:316-322
29. 2-adrenergic receptor density. J Cardiovasc Electrophysiol 1996; 7:1039-1049
30. 1-receptor down-regulation in heart failure. Circ Res 1986; 59:297-309
31. Fowler MB, Laser JA, Hopkins GL, et al. Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation 1986; 74:1290-1302
32. Mettauer B, Rouleau JL, Burgess JH. Detrimental arrhythmogenic and sustained beneficial effects of oral salbutamol in patients with chronic congestive cardiac failure. Am Heart J 1985; 109:840-847
33. Bengtsson B, Fagerstrom PO. Extrapulmonary effects of terbutaline during prolonged administration. Clin Pharmacol Ther 1982; 31:726-732